Skip to main content

Advertisement

Log in

Establishing and strengthening a medicine and therapeutics committee in a medical college in Nepal: initial experiences

  • Commentary
  • Published:
Pharmacy World & Science Aims and scope Submit manuscript

Abstract

Drug and Therapeutics Committees (DTCs) serve as a forum to bring together various stakeholders to improve drug use. DTCs are a key intervention to promote rational use of medicines. DTCs are however, functioning in only a limited number of hospitals in Nepal. A Medicine and Therapeutics Committee (MTC) was started at KIST Medical College, a new medical school in Lalitpur district, Nepal to promote the rational use of medicines in February 2008. The MTC has members from various departments and the full support of the administration. The MTC has been involved in preparing the hospital medicine list and limiting the number of brands available in the pharmacy. Measures to regulate pharmaceutical promotion have been undertaken. Pharmacovigilance and medication counseling activities have been started. Educational programs for various levels of staff are regularly carried out and drug use in the hospital is periodically monitored. Initial experiences regarding MTC functioning is positive.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Holloway K, Green T. Drug and Therapeutics Committees—A practical guide. Geneva: World Health organization; 2003.

    Google Scholar 

  2. Weekes LM, Brooks C. Drugs and Therapeutic Committees in Australia: expected and actual performance. Br J Clin Pharmacol. 1996;42:551–7.

    PubMed  CAS  Google Scholar 

  3. Thurmann PA, Harder S, Steioff A. Structure and activities of hospital drug committees in Germany. Eur J Clin Pharmacol. 1997;52:429–35. doi:10.1007/s002280050315.

    Article  PubMed  CAS  Google Scholar 

  4. Björkman IK, Schmidt IK, Holmström I, Bernsten CB. Developing the role of the drug and therapeutics committees: perceptions of chairs. Int J Health Care Qual Assur. 2007;20:161–78. doi:10.1108/09526860710731843.

    Article  PubMed  Google Scholar 

  5. Laing R, Hogerzeil HV, Ross-Degnan D. Ten recommendations to improve the use of medicines in developing countries. Health Policy Plan. 2001;16:13–20. doi:10.1093/heapol/16.1.13.

    Article  PubMed  CAS  Google Scholar 

  6. Mishra P, Alurkar VM, Subish P. Functions of a drug and therapeutics committee in Nepal. J Pharm Pract Res. 2006;36:81.

    Google Scholar 

  7. Palaian S, Mishra P. Role of drug and therapeutics committee towards drug safety-experiences from western Nepal. Kathmandu Univ Med J. 2005;3:79–80.

    CAS  Google Scholar 

  8. Palaian S, Mishra P, Shankar PR, Bista D, Purwar B. Contribution of the regional drug information center towards drug safety. JNMA J Nepal Med Assoc. 2006;45:216–8.

    PubMed  CAS  Google Scholar 

  9. Dartnell J. Activities to improve hospital prescribing. Aust Prescr. 2001;24:29–31.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Ravi Shankar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shankar, P.R., Humagain, B., Piryani, R.M. et al. Establishing and strengthening a medicine and therapeutics committee in a medical college in Nepal: initial experiences. Pharm World Sci 31, 241–245 (2009). https://doi.org/10.1007/s11096-008-9263-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-008-9263-y

Keywords

Navigation